Advertisement

Strahlentherapie und Onkologie

, Volume 195, Issue 2, pp 186–187 | Cite as

Genetische Risikofaktoren für ein Zweitmalignom bei Kindern nach einer ersten onkologischen Erkrankung

  • Martin G. SauerEmail author
Literatur kommentiert
  • 67 Downloads

Genetic risk factors for a second neoplasm in children who have survived a first malignant disease

Notes

Interessenkonflikt

M.G. Sauer gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD et al (2017) PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin. Cancer Res 23(12):e76–e82Google Scholar
  2. 2.
    Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC et al (2017) Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin. Cancer Res 23(11):e38–e45Google Scholar
  3. 3.
    Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA et al (2017) Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. Jama Oncol 3(12):1634–1639CrossRefGoogle Scholar
  4. 4.
    Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17(9):1295–1305CrossRefGoogle Scholar
  5. 5.
    Aravanis AM, Lee M, Klausner RD (2017) Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection. Cell 168(4):571–574CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatric Hematology and OncologyMedizinische Hochschule HannoverHannoverDeutschland

Personalised recommendations